686 evolution-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"Tampere-University" positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, metabolic liver disease and immune responses. We are an interdisciplinary research team working at the interfaces between nutrition and the development of metabolic diseases as well as healthy aging. We build
-
The Rosalind Franklin Institute (The Franklin) is the national institute for technology development for the life sciences in the UK – funded by the government through UK Research and Innovation
-
collaboration and inclusion. The opportunity to engage with world-class researchers and contribute to impactful science. Professional development opportunities through internal and external conferences and
-
educational reimbursement each year, and a significant budget for professional development. A competitive compensation package with comprehensive health and welfare benefits. Amenities that enhance work-life
-
of multimodal imaging concepts at the nanotomography station of P05 Development and adaptation of the existing in-situ nanotomography setups, fulfilling the demands of water-driven materials Design of experiments
-
Senior Bioinformatics Research Scientist - Northcott Lab in the Center of Excellence in Neuro-Oncolo
visualization, statistical analysis, experimental design, database development, mathematical modeling, and novel method development. Provides bioinformatics analysis for investigators and communicates analytical
-
-phonon coupling. You will contribute to the development of new dynamics software and machine learning methods for the computational design of catalyst materials. The employment duration is 3 years
-
technologies Preparing and supporting patent application documents Performing physics-based simulations to support process and device development Develop new application cases and proof-of-concept demonstrations
-
a deeper understanding of life, leading to potential acceleration of the development of safe, targeted, cell-based therapies, and opening entire new fields of research in human health. The project
-
second nationwide in terms of case mix index (case severity). In 2024, the UKB raised nearly €100 million in third-party funding for research, development, and teaching. The F.A.Z. Institute has named